SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022300
Filing Date
2020-05-07
Accepted
2020-05-07 06:06:20
Documents
49
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q onct-10q_20200331.htm 10-Q 1113544
2 EX-31.1 onct-ex311_7.htm EX-31.1 16964
3 EX-31.2 onct-ex312_6.htm EX-31.2 16948
4 EX-32.1 onct-ex321_9.htm EX-32.1 6742
5 EX-32.2 onct-ex322_14.htm EX-32.2 6932
  Complete submission text file 0001564590-20-022300.txt   3757797

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT onct-20200331.xml EX-101.INS 575891
7 XBRL TAXONOMY EXTENSION SCHEMA onct-20200331.xsd EX-101.SCH 43499
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE onct-20200331_cal.xml EX-101.CAL 29054
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE onct-20200331_def.xml EX-101.DEF 108167
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE onct-20200331_lab.xml EX-101.LAB 309788
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onct-20200331_pre.xml EX-101.PRE 216031
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50549 | Film No.: 20854375
SIC: 2834 Pharmaceutical Preparations